While these observations appear to contradict our findings, a more recent study reported USP44 promoter methylation in plasma cell-free DNA of metastatic prostate cancer patients, which was significantly associated with worse overall survival16. This evidence concerns the gene USP44 and metastatic prostate carcinoma.